NCNA
NuCana plcNASDAQHealthcare$1.68+3.07%ClosedMarket Cap: $10.2M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
0.19
P/S
0.00
EV/EBITDA
0.77
DCF Value
$8.80
FCF Yield
-95.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-189.9%
ROA
-98.5%
ROIC
-70.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-2.8M | $-2.5M | $-0.66 | — |
| FY 2025 | $0.00 | -Infinity% | $-20.4M | $-28.7M | $-7.75 | — |
| Q3 2025 | $0.00 | NaN% | $-779.0K | $-281.0K | $-0.08 | — |
| Q2 2025 | $0.00 | NaN% | $-11.8M | $-24.1M | $-4.00 | — |
| Q1 2025 | $0.00 | NaN% | $-2.9M | $-2.5M | $-100.00 | — |
| Q4 2024 | $0.00 | NaN% | $-865.0K | $-653.0K | $-0.12 | — |
| FY 2024 | $0.00 | NaN% | $-22.8M | $-19.0M | $-3.27 | — |
| Q3 2024 | $0.00 | NaN% | $-5.3M | $-4.5M | $-0.88 | — |
| Q2 2024 | $0.00 | NaN% | $-8.4M | $-7.0M | $-1.50 | — |
| Q1 2024 | $0.00 | NaN% | $-8.3M | $-6.8M | $-1.62 | — |
| Q4 2023 | $0.00 | NaN% | $-9.1M | $-7.7M | $-1.50 | — |
| FY 2023 | $0.00 | NaN% | $-32.8M | $-27.6M | $-5.25 | — |